New biomarker may guide best use of KRAS inhibitors in lung cancer
Lung cancer patients with high TTF-1 expression had improved survival outcomes following treatment with the KRAS inhibitor, sotorasib
This biomarker may help physicians determine those most likely to benefit from sotorasib and those who may need alternative or combination therapies
TTF-1 is a readily available biomarker commonly used for lung cancer diagnostics
Researchers from The University of Texas...
ASCO: MD Anderson’s Christopher Flowers honored for teaching and mentorship
Christopher Flowers, M.D., division head of Cancer Medicine and chair of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center...
CPRIT awards over $21 million to MD Anderson for cancer research and faculty recruitment
The University of Texas MD Anderson Cancer Center today was awarded $21.4 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer research efforts and faculty recruitment.
“We are grateful to CPRIT for its continued funding to support our efforts to lead impactful cancer research and to recruit exceptionally talented scientists to MD Anderson,” said Giulio Draetta, M.D., Ph.D., chief scientific...
UT MD Anderson and Texas Children’s Hospital announce $150 million gift from Kinder Foundation to launch Kinder Children’s Cancer Center
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital today announced a $150 million gift from Kinder Foundation...